Gavin Y. Oudit

Active 1999–2025

Also published as
Gavin Y Oudit
168
Papers
27,178
Citations
89
h-index
163
i10-index

Citations

Citations per year for Gavin Y. Oudit1982: 1 citations1983: 1 citations1986: 1 citations1988: 1 citations1997: 1 citations1999: 1 citations2000: 1 citations2001: 1 citations2002: 7 citations2003: 57 citations2004: 86 citations2005: 115 citations2006: 148 citations2007: 153 citations2008: 132 citations2009: 158 citations2010: 188 citations2011: 169 citations2012: 224 citations2013: 198 citations2014: 232 citations2015: 188 citations2016: 173 citations2017: 186 citations2018: 215 citations2019: 684 citations2020: 2,432 citations2021: 1,926 citations2022: 1,188 citations2023: 763 citations2024: 1,122 citations2025: 543 citations2026: 18 citations1984–1985: no citations, so these years are not shown1987: no citations, so this year is not shown1989–1996: no citations, so these years are not shown1998: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,962 citing papers, 22.5% of this breakdownChina: 1,705 citing papers, 12.9% of this breakdownCanada: 809 citing papers, 6.1% of this breakdownUnited Kingdom: 766 citing papers, 5.8% of this breakdownItaly: 683 citing papers, 5.2% of this breakdownGermany: 665 citing papers, 5.1% of this breakdownIndia: 328 citing papers, 2.5% of this breakdownAustralia: 320 citing papers, 2.4% of this breakdownJapan: 304 citing papers, 2.3% of this breakdownFrance: 303 citing papers, 2.3% of this breakdownNetherlands: 286 citing papers, 2.2% of this breakdownBrazil: 262 citing papers, 2% of this breakdown
0%22.5%Other 28.7%

Fields

  • Medicine70.7%
  • Biochemistry, Genetics and Molecular Biology20.4%
  • Neuroscience2.8%
  • Immunology and Microbiology2%
  • Nursing0.8%
  • Engineering0.6%
  • Other2.7%

Topics

  • COVID-19 Clinical Research Studies6.8%
  • SARS-CoV-2 and COVID-19 Research4.1%
  • Long-Term Effects of COVID-193.4%
  • Renin-Angiotensin System Studies3.2%
  • Cardiovascular Function and Risk Factors2.9%
  • Cardiac Fibrosis and Remodeling2.6%
  • Other77%

Coauthors

All papers

Open in search
  1. Cells of the adult human heart

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michela Noseda, Norbert Hübner, Sarah A. Teichmann - Nature 2020 cited by 1,823

  2. Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System

    Authors: , , , , , , , , - Circulation Research 2020 cited by 1,907

  3. Pathogenic variants damage cell composition and single cell transcription in cardiomyopathies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Masatoshi Kanda, Ruoyan Li, Lukáš Mach, Barbara McDonough, Sara Samari, Farnoush Shahriaran, Clarence Yapp, Caroline Stanasiuk, Pantazis Theotokis, Fabian J. Theis, Antoon van den Bogaerdt, Hiroko Wakimoto, James S. Ware, Catherine L. Worth, Paul J.R. Barton, Young‐Ae Lee, Sarah A. Teichmann, Hendrik Milting, Michela Noseda, Gavin Y. Oudit, Matthias Heinig, Jonathan G. Seidman, Norbert Hübner, Christine E. Seidman - Science 2022 cited by 237

  4. Restructuring of the Gut Microbiome by Intermittent Fasting Prevents Retinopathy and Prolongs Survival in db/db Mice

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Diabetes 2018 cited by 385

  5. Empagliflozin Increases Cardiac Energy Production in Diabetes

    Authors: , , , , , , , , , , , , - JACC Basic to Translational Science 2018 cited by 376

  6. Cancer Therapy–Related Hypertension: A Scientific Statement From the American Heart Association

    Authors: , , , , , , , , - Hypertension 2023 cited by 147

  7. Mitochondrial fatty acid oxidation is the major source of cardiac adenosine triphosphate production in heart failure with preserved ejection fraction

    Authors: , , , , , , , , , , , , , , , - Cardiovascular Research 2024 cited by 78

  8. Role of the ACE2/Angiotensin 1–7 Axis of the Renin–Angiotensin System in Heart Failure

    Authors: , , , - Circulation Research 2016 cited by 859

  9. The renin-angiotensin system: going beyond the classical paradigms

    Authors: , , , , , - American Journal of Physiology-Heart and Circulatory Physiology 2019 cited by 347

  10. Angiotensin-converting enzyme 2—at the heart of the COVID-19 pandemic

    Authors: , , , , - Cell 2023 cited by 129

  11. Circadian rhythm disorganization produces profound cardiovascular and renal disease in hamsters

    Authors: , , , , , , , , , - American Journal of Physiology-Regulatory, American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 2008 cited by 319

  12. Impaired branched chain amino acid oxidation contributes to cardiac insulin resistance in heart failure

    Authors: , , , , , , , , , , , , , , , , - Cardiovascular Diabetology 2019 cited by 176

  13. Metabolomic Fingerprint of Heart Failure with Preserved Ejection Fraction

    Authors: , , , , , , , , , , , - PLoS ONE 2015 cited by 218

  14. Epicardial adipose tissue as a metabolic transducer: role in heart failure and coronary artery disease

    Authors: , , , - Heart Failure Reviews 2017 cited by 212

  15. Sequential multi-omics analysis identifies clinical phenotypes and predictive biomarkers for long COVID

    Authors: , , , , , , , , , , , , - Cell Reports Medicine 2023 cited by 68

  16. Role of iron metabolism in heart failure: From iron deficiency to iron overload

    Authors: , , , - Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018 cited by 180

  17. Tissue Inhibitor of Matrix Metalloproteinase-1 Promotes Myocardial Fibrosis by Mediating CD63–Integrin β1 Interaction

    Authors: , , , , , - Hypertension 2017 cited by 169

  18. Angiotensin-converting enzyme 2 is an essential regulator of heart function

    Authors: , , , , , , , , , , , , , , , , - Nature 2002 cited by 1,774

  19. Multidisciplinary Approach to Novel Therapies in Cardio-Oncology Research (MANTICORE 101–Breast): A Randomized Trial for the Prevention of Trastuzumab-Associated Cardiotoxicity

    Authors: , , , , , , , , , , , , , - Journal of Clinical Oncology 2017 cited by 401

  20. L-type Ca2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy

    Authors: , , , , , , , , , , - Nature Medicine 2003 cited by 482

  21. Iron-Overload Cardiomyopathy: Pathophysiology, Diagnosis, and Treatment

    Authors: , - Journal of Cardiac Failure 2010 cited by 298

  22. Angiotensin-Converting Enzyme 2 Suppresses Pathological Hypertrophy, Myocardial Fibrosis, and Cardiac Dysfunction

    Authors: , , , , , , , , , , - Circulation 2010 cited by 459

  23. Pressure-overload-induced heart failure induces a selective reduction in glucose oxidation at physiological afterload

    Authors: , , , , , , , - Cardiovascular Research 2012 cited by 142

  24. Elevated Inflammatory Plasma Biomarkers in Patients With Fabry Disease: A Critical Link to Heart Failure With Preserved Ejection Fraction

    Authors: , , , , , , , , - Journal of the American Heart Association 2018 cited by 89